Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869167 · ClinicalTrials.gov registry record · Phase 3
Ramelteon for Insomnia Comorbid With Asthma
A Phase 3 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 2
- Enrollment target
NCT00869167 is a Phase 3 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 2 participants.
The verdict
NCT00869167, a Phase 3 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 2 participants
- Enrollment target
Study Summary
This trial will test the efficacy and safety of ramelteon, a selective melatonin agonist, on patients with insomnia comorbid with asthma.
Interventions
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869167
The ClinicalTrials.gov registry entry for NCT00869167 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ramelteon is the first listed.
NCT00869167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869167 about?
NCT00869167 is a clinical study titled "Ramelteon for Insomnia Comorbid With Asthma". This trial will test the efficacy and safety of ramelteon, a selective melatonin agonist, on patients with insomnia comorbid with asthma.
What is the current status of trial NCT00869167?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 2 participants. The study started on 2008-03. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00869167?
The interventions under investigation include: Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00869167?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.